--- a
+++ b/clusters/9knumclustersv2/clust_1111.txt
@@ -0,0 +1,110 @@
+PARTICIPANTS NOT ON THE HODGKIN LYMPHOMA EXPANSION COHORT: AST (serum glutamic oxaloacetic transaminase [SGOT])/ALT (serum glutamate pyruvate transaminase [SGPT]) =<  X ULN, within  weeks prior to enrollment
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < . x upper limit of normal for patients without liver metastases OR SGOT and SGPT <  x upper limit of normal for patients with liver metastases
+Patients must have serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =< . x IULN within  days prior to registration
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) >= . times upper limit of normal (ULN)
+Serum glutamic-oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) =<  x laboratory normal
+Serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) < . x institutional upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) within  days prior to registration\r\n* It is highly recommended but not required that SGOT or SGPT be =< . upper limit of normal
+Serum glutamate pyruvate transaminase (SGPT)/serum glutamic oxaloacetic transaminase (SGOT) =<  X ULN
+PART I: Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =<  x the upper limits of normal
+Patients with active hepatitis with serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) equal or greater than  times normal
+Patients should also have a serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) less than  times the upper limit of normal
+Bilirubin, liver alkaline phosphatase, serum glutamic-oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal
+Serum glutamic-oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) =< . x upper limit of normal (ULN) if no liver metastasis present; SGOT, SGPT =<  x ULN if liver metastasis present
+Serum glutamate pyruvate transaminase (SGPT) =< to . x normal.
+Serum glutamic-oxaloacetic transaminase (SGOT) and/or serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal (ULN)
+AST (serum glutamic-oxaloacetic transaminase [SGOT]) > . X institutional ULN and ALT (serum glutamate pyruvate transaminase [SGPT]) > . X institutional ULN
+Patients should also have a serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) less than  times the upper limit of normal
+Serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =<  x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) and/or serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) and/or serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =< . times the institutional upper limits of normal
+Patients must have adequate organ function and performance status at the time of the CD+ memory T-cell infusion, defined by the following:\r\n* Total bilirubin =<  mg/dL\r\n* Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal (ULN)\r\n* Creatinine =<  mg/dL or estimated creatinine clearance >=  ml/min
+Serum glutamate pyruvate transaminase (SGPT) or serum glutamic oxaloacetic transaminase (SGOT) <  x upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) AND serum glutamate pyruvate transaminase (SGPT) <  x normal except in cases where abnormal LFTS are due to involvement with T-NHL
+Serum glutamic oxaloacetic transaminase (SGOT) and/or serum glutamate pyruvate transaminase (SGPT) > . times the institutional upper limit of normal (ULN)
+Serum glutamate pyruvate transaminase (SGPT) or serum glutamic oxaloacetic transaminase (SGOT) =<  x upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =<  x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) >  x normal
+Serum glutamic-oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) <  x upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) and /or serum glutamate pyruvate transaminase (SGPT) > . times the institutional upper limit of normal
+Serum glutamate pyruvate transaminase (SGPT), serum glutamic oxaloacetic transaminase (SGOT) less than  x the upper limit of normal range (unless related to Gilberts disease or medications)
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =<  x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < . x institutional upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) =<  x normal except in cases where abnormal liver function tests (LFTS) are due to involvement with HL
+Serum glutamate pyruvate transaminase (SGPT) or serum glutamic oxaloacetic transaminase (SGOT) =<  x upper limit of normal (ULN) unless considered due to tumor
+Serum glutamic oxaloacetic transaminase (SGOT) and /or serum glutamate pyruvate transaminase (SGPT) > . times the institutional upper limit of normal
+Either serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) < . x IULN, obtained within  days prior to registration
+Patients must have serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =< . times the institutional upper limits of normal
+Transaminases (serum glutamic oxaloacetic transaminase [SGOT] and/or serum glutamate pyruvate transaminase [SGPT]) must be =<  x upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) and/or serum glutamate pyruvate transaminase (SGPT) > . times the institutional upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) less than or equal to  x upper limit of normal (ULN)
+Subjects baseline serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) must be < . x institutional upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) <  x upper limit of institutional normal (ULN)
+Serum glutamate pyruvate transaminase (SGPT) =< to . x normal
+Serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) =< . x ULN
+serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < . x upper limit of normal for patients without liver metastases
+Serum glutamic oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) =< . x upper limits of normal
+Serum glutamate pyruvate transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT) < . times normal
+Serum glutamate pyruvate transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT) =< . x upper limit of normal (ULN), unless elevated secondary to disease
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) >  x normal
+Pretreatment serum glutamic oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) =< . x institutional upper limit of normal (ULN)
+Pretreatment serum glutamic oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) =< . x institutional upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =<  x ULN
+Serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) <  x upper limit of institutional normal (ULN)
+Patients must have serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =< . times the institutional upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamic pyruvate transaminase (SGPT) =< four times the upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) =< . x upper limit of normal (ULN) or =<  x ULN if liver metastases is present
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) =< . x ULN (if liver metastases are present, SGOT or SGPT must be =< . x IULN)
+AST (serum glutamic oxaloacetic transaminase [SGOT])/ALT (serum glutamate pyruvate transaminase [SGPT]) =< . x IULN
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =< . x ULN obtained within  days prior to registration
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) >  x upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =< . times the institutional upper limits of normal
+Serum glutamic oxaloacetic transaminase (SGOT) =< . x ULN and serum glutamate pyruvate transaminase (SGPT) =< . x ULN
+Transaminases (serum glutamic oxaloacetic transaminase [SGOT] and/or serum glutamate pyruvate transaminase [SGPT]) must be less than . X the institutional upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < . times upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) < . x ULN for age
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) =< . x the institutional upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) =< . x institutional upper limit of normal (ULN)
+Obtained within  weeks from study entry: Serum glutamic oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) =<  x ULN if no liver metastasis present
+Serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) =< . times the institutional upper limit of normal (unless due to disease involvement of liver)
+Serum glutamate pyruvate transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT) <  x the institutional upper limit of normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < . x upper limit of normal for patients without liver metastases OR SGOT and SGPT <  x upper limit of normal for patients with liver metastases
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) =< . x normal prior to biopsy
+Serum glutamate pyruvate transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT) < . times normal
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) both =<  times upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) within the institutional ULN
+Serum glutamic-oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) =<  X the upper limit of normal (ULN) for the reference lab unless due to leukemia
+Serum glutamic pyruvate transaminase (SGPT) =<  IU/ml unless related to patient's malignancy
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =<  times upper limit of laboratory normal
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) =<  x the institutional upper limit of normal within  days prior to registration
+Patients at high risk of veno-occlusive disease of the liver (criteria not yet rigorously defined but includes bilirubin > . mg and serum glutamic oxaloacetic transaminase [SGOT] or serum glutamate pyruvate transaminase [SGPT] >  x normal); patients may be accepted outside of this range if cleared by gastrointestinal (GI) consult
+Serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < . x upper limits of normal
+Serum glutamate pyruvate transaminase (SGPT) equal or less than  x normal values
+Serum glutamate pyruvate transaminase (SGPT) and/or serum glutamic oxaloacetic transaminase (SGOT) =< . x ULN
+Transaminases (serum glutamic oxaloacetic transaminase [SGOT] and/or serum glutamate pyruvate transaminase [SGPT]) =< . times institutional ULN
+Serum glutamate pyruvate transaminase (SGPT) or serum glutamic oxaloacetic transaminase (SGOT) less than or equal to . x upper limit of normal (ULN) unless considered due to tumor or hemolysis
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < . x upper limit of normal for patients without liver metastases OR SGOT and SGPT <  x upper limit of normal for patients with liver metastases
+Serum glutamate pyruvate transaminase (SGPT) =< to . x normal
+Serum glutamic-oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) less than twice the upper limit of normal
+AST (serum glutamic oxaloacetic transaminase [SGOT])/ALT (serum glutamate pyruvate transaminase [SGPT]) =< . x IULN
+Serum glutamic oxaloacetic transaminase (SGOT) and/or serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal
+Serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) less than five times the institutional upper limits of normal
+Transaminases (serum glutamic oxaloacetic transaminase [SGOT] and/or serum glutamate pyruvate transaminase [SGPT]) must be less than . X upper limit of normal (ULN) concomitant with alkaline phosphatase less than  X the ULN
+Serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) <  times upper limit of normal (ULN)
+Serum glutamic-oxaloacetic transaminase (SGOT) and/or serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal (ULN)
+Serum glutamic-oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) < . x ULN; for subjects with known liver metastases <  x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) <  x upper limit of institutional normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) less than . x NL for age
+Patients should also have a serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) less than  times the upper limit of normal
+Serum glutamic-oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) =<  x upper limit of normal
+Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) <  x upper limit of institutional normal (ULN)
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) =< . times upper limit of normal
+Within  days prior to study entry: Serum glutamic oxaloacetic transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) < . X institutional upper limit of normal (ULN) (<  X ULN if known liver metastases)
+Serum glutamic oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) less than . times below or above the upper or lower limit range
+Patients should have adequate hepatic function with a total bilirubin within normal range and serum glutamate oxaloacetate transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT) < two times the upper limit of normal (ULN) for patients without liver metastasis and SGOT or SGPT < five times ULN for those with liver metastasis, and adequate renal function as defined by a serum creatinine within . times the upper limit of normal.
+Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < . x upper limit of normal for patients without liver metastases or SGOT and SGPT <  x upper limit of normal for patients with liver metastases